📰 Programmed Cell Death News
Page 2 - Programmed Cell Death News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Programmed Cell Death. Real-time updates on events, politics, business and more.
November 1, 2023
UTA will soon add a new piece of cutting-edge equipment to its already impressive and growing research armamentarium-;a type of super-resolution microscope (SRM) that allows biologists to see structures within a cell in even finer detail.
October 28, 2023
Announcing a new publication for Acta Materia Medica journal. The role of cuproptosis, a newly discovered form of programmed cell death, remains poorly understood in hepatocellular carcinoma (HCC).
October 24, 2023
A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.
October 10, 2023
A marine sponge from Mauritius has shown potential as the source of compounds that kill liver cancer cells.
October 4, 2023
Your cells die to keep you alive. Cell death does everything from fighting cancer cells and pathogens to forming your fingers and toes.
August 28, 2023
The review summarized the involvement of mitochondria in age-related disease progression and highlighted its potential as a therapeutic target of these diseases.
August 10, 2023
Researchers elucidate the role of cell death in the pathogenesis of different diseases.
August 7, 2023
/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...
August 4, 2023
Researchers investigated the complex relationship between gut bacteria, diet, and patient nutrition.
August 1, 2023
Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.